Wan Feng
Professor
Doctoral Supervisor
Foreign Academician of France, National Renowned Doctor
Director, Clinical Research Institute of Cardiovascular Disease, Shanghai Yida Hospital
Discipline Leader, Cardiac and Great Vessel Surgery, Shanghai Yida Hospital
Founder of Minimally Invasive Off-Pump Coronary Bypass Surgery in China
Pioneer of Ventricular Assist Device Application in China
Graduated from Xiangya Medical College, Hunan, in 1983 and was assigned to the Department of Cardiac Surgery at Fuwai Hospital, Chinese Academy of Medical Sciences; studied in Europe and the United States from 1988 and, after returning to China in 1996, successively served as Director of Cardiac Surgery at Peking University People's Hospital, Director of Cardiac Surgery at Peking University Third Hospital, Head of the Department of Cardiovascular Surgery at Peking University Health Science Center, and Director / Honorary Director / Chief Consultant of Cardiac and Great Vessel Surgery at Shanghai East Hospital affiliated to Tongji University.
Founder of minimally invasive off-pump coronary bypass surgery in China and pioneer of ventricular assist device application in China; he was the first in China to perform minimally invasive off-pump coronary artery bypass (OPCAB) surgery, ventricular assist device (VAD) implantation and transmyocardial laser revascularization (TMLR). To date he has completed more than 20,000 cardiac surgery operations of various types, with case volumes and success rates at internationally leading levels. He currently serves as Director of the Clinical Research Institute of Cardiovascular Disease and Discipline Leader of Cardiac and Great Vessel Surgery at Shanghai University School of Medicine.
Off-pump coronary artery bypass surgery, minimally invasive small-incision heart surgery, heart valve repair, diagnosis and treatment of complex congenital heart disease in children, transmyocardial laser revascularization, heart-lung transplantation and ventricular assist devices, and surgical treatment of all types of complex heart disease; as well as stem cell and comprehensive clinical surgical treatment for patients with complex heart failure.
More than 100 academic papers (in Chinese and English) published, and 7 books
First Prize for Scientific and Technological Progress, Ministry of Education
Second Prize for Scientific and Technological Progress, Ministry of Information Industry
Third Prize, Chinese Medical Science and Technology Award
Wu Jieping Medical Research Achievement Award
A dynamic magnetic balance maglev centrifugal blood pump, Patent No. ZL201711266131.4, first inventor
A biventricular assist centrifugal blood pump, Patent No. 202311849700.3, first inventor
A liquid maglev axial-flow blood pump, Patent No. ZL201410451079.x, first inventor
A training device for simulating cardiac surgery, Patent No. ZL202020639433.2, first inventor
A ventricular aneurysm closure device, Patent No. ZL202022899942.1, first inventor
A cardiac bionic device, Patent No. ZL202020647563.0, first inventor
Founding President / Honorary President, Society of Cardiovascular Surgeons, Chinese Medical Doctor Association
Chairman, Heart Failure Committee, Society of Cardiovascular Surgeons, Chinese Medical Doctor Association
Founding Head, Department of Cardiovascular Surgery, Peking University Health Science Center
Chairman, Society of Cardiovascular Surgery, Physicians Association, Western Returned Scholars Association
Director, China Division, Starr-Wood Cardiac Group, United States
Former Editor-in-Chief / Honorary Editor-in-Chief, Chinese Journal of Cardiovascular Research
Starr International Group,Ltd. President/CEO
President/CEO, Starr International Group, Ltd.
Chairman, Yangtze River Delta Cardiopulmonary Rescue Alliance, Health News Agency
President, Society of Physician Groups, China Non-government Medical Institutions Association
